The first thought to cross many American’s minds when coming to terms with a chronic illness isn’t whether they will live, but whether they – and their families – can financially survive.
In addition to lacking universal healthcare, the U.S. also has prescription drug prices that are on average 2.56 times higher than other countries around the world. That number increases to 3.44 when dealing with name brands, according to a study by RAND, a nonpartisan, nonprofit research organization.
“Brand-name drugs are the primary driver of the higher prescription drug prices in the United States,” said Andrew Mulcahy, lead author of the study and a senior health policy researcher at RAND, in a news release. “We found consistently high U.S. brand name prices regardless of our methodological decisions.”
While the health care discussion has dominated U.S. airwaves for years, the issue has become even more hotly debated during COVID-19 times.
The health crisis has not only disrupted insurance coverages, provider coverages, and public health, but has also brought to the forefront the racial and ethnic disparities that exist in the U.S. health care system.
Even prior to the global pandemic, U.S. healthcare spending reached $3.6 trillion in 2018, with 14% of that devoted to the purchase of prescription drugs.
A Cheaper Way
Biotech companies, such as EQRx, meanwhile, are researching ways to create and sell pharmaceutical drugs at lower costs, making them more affordable for everyday Americans.
EQRx announced earlier this year that it had raised $500 million in Series B financing, increasing its total funding to $750 million.
This story is from the May 2021 edition of The BOSS Magazine.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 2021 edition of The BOSS Magazine.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Life in pink
La Vie en Rose, Canada's beloved specialty retailer, is on the verge of completing a seven-year digital transformation. Here's how they did it.
TRAIN YOUR BRAIN FOR LONG TERM HEALTH
WHEN IT COMES TO BRAIN FITNESS, SIMPLE CHANGES CAN YIELD SUPERIOR RESULTS
FREEDOM OF CHOICE
MENU CUSTOMIZATION IS EMPOWERING DINERS AND DRIVING BIG REVENUES
GETTING TO GIVE
VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF DENTISTRY MERGES EXCELLENCE AND UNIMPEACHABLE IN BUSINESS CARE WITH BLOCKBUSTER RESULTS
LITTLE BY LITTLE
NANOTECHNOLOGY IS IMPROVING MANUFACTURING IN WAYS BIG AND SMALL
The Heart of Hospitality
For procurement and supply chain leader Provista, creating a true community of c customers is the secret to their success
'AS BIG AS THE INTERNET, IF NOT BIGGER'
THE HOSTS OF AI FOR HUMANS ON AI'S POTENTIAL FOR GOOD, BAD, AND DOWNRIGHT SILLY
They Have It Covered
Yong Lee (Lee) and PHP Agency use tech innovations to inject life back into life insurance
SEE FARTHER, MOVE FASTER
BUILDING TRULY AGILE SUPPLY CHAINS
Flavor Fascination
AS A UNIQUE GLOBAL FLAVOR DEVELOPER, CITROMAX BUILDS ITS HERITAGE AND SUCCESS ON TASTE AND A QUEST TO BRING NEW SENSATIONS TO THE TABLE